Raska K, Kim H C, Raska K, Martin E, Raskova J, Saidi P
Department of Pathology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854-5635.
Clin Exp Immunol. 1989 Jul;77(1):1-6.
To identify markers of prognostic value in the course of HIV disease, immunologic parameters and profiles of HIV antibodies and antigen were studied in 60 haemophiliacs. The 43 HIV-seropositive subjects were followed prospectively over a 4 year period with a retrospective analysis as well of their frozen plasma for HIV markers. This group had a significant decrease in number of helper/inducer T lymphocytes as compared with 17 HIV seronegative subjects. The degree of changes correlated with the stage of disease, with the most severe depletion of CD4 cells in those who developed AIDS. Counts of B cells and platelets were also lower in HIV-infected haemophiliacs. Ten out of 12 AIDS patients had undetectable antibodies to HIV p24 antigen; low levels of p24 antibody were also seen in six out of 15 subjects with lymphadenopathy (CDC stage III), but in only two out of 16 asymptomatic subjects (CDC stage II). Sustained HIV p24 antigenaemia (greater than 30 pg/ml) was seen in 10 AIDS patients, in five subjects with lymphadenopathy and in two asymptomatic haemophiliacs. Initial HIV serologic profiles, obtained when all patients were asymptomatic, were highly predictive for progression of the HIV infection: the initial pattern of low anti-p24 antibody and positive p24 antigenaemia conferred the worst prognosis, with all patients in this group developing ARC or AIDS within 36 months, whereas an initial high level of anti-p24 without p24 antigenaemia was associated with relatively the best prognosis. Of such subjects, 58% have remained clinically asymptomatic after 48 months of the study (P less than 0.00001). The serologic profile of HIV antibody pattern and HIV antigen in haemophilic patients thus already provides important prognostic information at an early stage of HIV infection.
为了确定HIV疾病进程中具有预后价值的标志物,对60名血友病患者的免疫参数以及HIV抗体和抗原谱进行了研究。对43名HIV血清阳性受试者进行了为期4年的前瞻性随访,并对其冷冻血浆中的HIV标志物进行了回顾性分析。与17名HIV血清阴性受试者相比,该组辅助/诱导性T淋巴细胞数量显著减少。变化程度与疾病阶段相关,发展为艾滋病的患者CD4细胞耗竭最为严重。HIV感染的血友病患者的B细胞和血小板计数也较低。12名艾滋病患者中有10名检测不到HIV p24抗原抗体;15名淋巴结病患者(疾病控制中心III期)中有6名p24抗体水平较低,但16名无症状受试者(疾病控制中心II期)中只有2名。10名艾滋病患者、5名淋巴结病患者和2名无症状血友病患者出现持续性HIV p24抗原血症(大于30 pg/ml)。所有患者无症状时获得的初始HIV血清学谱对HIV感染的进展具有高度预测性:初始低抗p24抗体和p24抗原血症阳性的模式预后最差,该组所有患者在36个月内发展为艾滋病相关综合征或艾滋病,而初始高抗p24水平且无p24抗原血症的患者预后相对最佳。在研究48个月后,这类受试者中有58%仍无临床症状(P小于0.00001)。因此,血友病患者的HIV抗体模式和HIV抗原的血清学谱在HIV感染早期就已经提供了重要的预后信息。